Cartesian Therapeutics
RNAC
#6941
Rank
A$0.71 B
Marketcap
$28.30
Share price
-2.21%
Change (1 day)
-13.33%
Change (1 year)

Cartesian Therapeutics (RNAC) - Total debt

Total debt on the balance sheet as of September 2024 : A$23.16 Million

According to Cartesian Therapeutics's latest financial reports the company's total debt is A$23.16 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Cartesian Therapeutics - Total debt on balance sheet (from 2015 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$16.07 M-71.15%
2022-12-31A$55.73 M14.52%
2021-12-31A$48.66 M5.86%
2020-12-31A$45.97 M66.96%
2019-12-31A$27.53 M-9.3%
2018-12-31A$30.35 M12.63%
2017-12-31A$26.95 M61.31%
2016-12-31A$16.7 M2.67%
2015-12-31A$16.27 M79.93%
2014-12-31A$9.04 M